The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Cardiopulmonary Autotransfusion Systems-Global Market Insights and Sales Trends 2024

Cardiopulmonary Autotransfusion Systems-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1855072

No of Pages : 103

Ask Your Query
Synopsis
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Cardiopulmonary Autotransfusion Systems market size is expected to reach US$ 655.2 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Cardiopulmonary Autotransfusion Systems in various end use industries. The expanding demands from the Heart Surgery, Great Organ Transplant Surgery and Others,, are propelling Cardiopulmonary Autotransfusion Systems market. Unwashed ATS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Washed ATS segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiopulmonary Autotransfusion Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiopulmonary Autotransfusion Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiopulmonary Autotransfusion Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiopulmonary Autotransfusion Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiopulmonary Autotransfusion Systems covered in this report include Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Atrium Medical, Global Blood Resources and Redax, etc.
The global Cardiopulmonary Autotransfusion Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker
Global Cardiopulmonary Autotransfusion Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiopulmonary Autotransfusion Systems market, Segment by Type:
Unwashed ATS
Washed ATS
Global Cardiopulmonary Autotransfusion Systems market, by Application
Heart Surgery
Great Organ Transplant Surgery
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cardiopulmonary Autotransfusion Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cardiopulmonary Autotransfusion Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Cardiopulmonary Autotransfusion Systems Market Overview
1.1 Cardiopulmonary Autotransfusion Systems Product Overview
1.2 Cardiopulmonary Autotransfusion Systems Market Segment by Type
1.2.1 Unwashed ATS
1.2.2 Washed ATS
1.3 Global Cardiopulmonary Autotransfusion Systems Market Size by Type
1.3.1 Global Cardiopulmonary Autotransfusion Systems Market Size Overview by Type (2018-2029)
1.3.2 Global Cardiopulmonary Autotransfusion Systems Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cardiopulmonary Autotransfusion Systems Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cardiopulmonary Autotransfusion Systems Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cardiopulmonary Autotransfusion Systems Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales Breakdown by Type (2018-2023)
2 Global Cardiopulmonary Autotransfusion Systems Market Competition by Company
2.1 Global Top Players by Cardiopulmonary Autotransfusion Systems Sales (2018-2023)
2.2 Global Top Players by Cardiopulmonary Autotransfusion Systems Revenue (2018-2023)
2.3 Global Top Players by Cardiopulmonary Autotransfusion Systems Price (2018-2023)
2.4 Global Top Manufacturers Cardiopulmonary Autotransfusion Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cardiopulmonary Autotransfusion Systems Market Competitive Situation and Trends
2.5.1 Cardiopulmonary Autotransfusion Systems Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cardiopulmonary Autotransfusion Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Cardiopulmonary Autotransfusion Systems Market
2.8 Key Manufacturers Cardiopulmonary Autotransfusion Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cardiopulmonary Autotransfusion Systems Status and Outlook by Region
3.1 Global Cardiopulmonary Autotransfusion Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cardiopulmonary Autotransfusion Systems Historic Market Size by Region
3.2.1 Global Cardiopulmonary Autotransfusion Systems Sales in Volume by Region (2018-2023)
3.2.2 Global Cardiopulmonary Autotransfusion Systems Sales in Value by Region (2018-2023)
3.2.3 Global Cardiopulmonary Autotransfusion Systems Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Region
3.3.1 Global Cardiopulmonary Autotransfusion Systems Sales in Volume by Region (2024-2029)
3.3.2 Global Cardiopulmonary Autotransfusion Systems Sales in Value by Region (2024-2029)
3.3.3 Global Cardiopulmonary Autotransfusion Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cardiopulmonary Autotransfusion Systems by Application
4.1 Cardiopulmonary Autotransfusion Systems Market Segment by Application
4.1.1 Heart Surgery
4.1.2 Great Organ Transplant Surgery
4.1.3 Others
4.2 Global Cardiopulmonary Autotransfusion Systems Market Size by Application
4.2.1 Global Cardiopulmonary Autotransfusion Systems Market Size Overview by Application (2018-2029)
4.2.2 Global Cardiopulmonary Autotransfusion Systems Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cardiopulmonary Autotransfusion Systems Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cardiopulmonary Autotransfusion Systems Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cardiopulmonary Autotransfusion Systems Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales Breakdown by Application (2018-2023)
5 North America Cardiopulmonary Autotransfusion Systems by Country
5.1 North America Cardiopulmonary Autotransfusion Systems Historic Market Size by Country
5.1.1 North America Cardiopulmonary Autotransfusion Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2018-2023)
5.1.3 North America Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2018-2023)
5.2 North America Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Country
5.2.1 North America Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2024-2029)
5.2.2 North America Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2024-2029)
6 Europe Cardiopulmonary Autotransfusion Systems by Country
6.1 Europe Cardiopulmonary Autotransfusion Systems Historic Market Size by Country
6.1.1 Europe Cardiopulmonary Autotransfusion Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2018-2023)
6.1.3 Europe Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2018-2023)
6.2 Europe Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Country
6.2.1 Europe Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2024-2029)
6.2.2 Europe Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2024-2029)
7 Asia-Pacific Cardiopulmonary Autotransfusion Systems by Region
7.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Historic Market Size by Region
7.1.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales in Value by Region (2024-2029)
8 Latin America Cardiopulmonary Autotransfusion Systems by Country
8.1 Latin America Cardiopulmonary Autotransfusion Systems Historic Market Size by Country
8.1.1 Latin America Cardiopulmonary Autotransfusion Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2018-2023)
8.2 Latin America Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Country
8.2.1 Latin America Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2024-2029)
9 Middle East and Africa Cardiopulmonary Autotransfusion Systems by Country
9.1 Middle East and Africa Cardiopulmonary Autotransfusion Systems Historic Market Size by Country
9.1.1 Middle East and Africa Cardiopulmonary Autotransfusion Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cardiopulmonary Autotransfusion Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Advancis Surgical
10.1.1 Advancis Surgical Company Information
10.1.2 Advancis Surgical Introduction and Business Overview
10.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Advancis Surgical Cardiopulmonary Autotransfusion Systems Products Offered
10.1.5 Advancis Surgical Recent Development
10.2 Fresenius Kabi
10.2.1 Fresenius Kabi Company Information
10.2.2 Fresenius Kabi Introduction and Business Overview
10.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Products Offered
10.2.5 Fresenius Kabi Recent Development
10.3 Haemonetics
10.3.1 Haemonetics Company Information
10.3.2 Haemonetics Introduction and Business Overview
10.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Haemonetics Cardiopulmonary Autotransfusion Systems Products Offered
10.3.5 Haemonetics Recent Development
10.4 LivaNova
10.4.1 LivaNova Company Information
10.4.2 LivaNova Introduction and Business Overview
10.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.4.4 LivaNova Cardiopulmonary Autotransfusion Systems Products Offered
10.4.5 LivaNova Recent Development
10.5 Medtronic
10.5.1 Medtronic Company Information
10.5.2 Medtronic Introduction and Business Overview
10.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Medtronic Cardiopulmonary Autotransfusion Systems Products Offered
10.5.5 Medtronic Recent Development
10.6 Terumo
10.6.1 Terumo Company Information
10.6.2 Terumo Introduction and Business Overview
10.6.3 Terumo Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Terumo Cardiopulmonary Autotransfusion Systems Products Offered
10.6.5 Terumo Recent Development
10.7 Atrium Medical
10.7.1 Atrium Medical Company Information
10.7.2 Atrium Medical Introduction and Business Overview
10.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Atrium Medical Cardiopulmonary Autotransfusion Systems Products Offered
10.7.5 Atrium Medical Recent Development
10.8 Global Blood Resources
10.8.1 Global Blood Resources Company Information
10.8.2 Global Blood Resources Introduction and Business Overview
10.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Global Blood Resources Cardiopulmonary Autotransfusion Systems Products Offered
10.8.5 Global Blood Resources Recent Development
10.9 Redax
10.9.1 Redax Company Information
10.9.2 Redax Introduction and Business Overview
10.9.3 Redax Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Redax Cardiopulmonary Autotransfusion Systems Products Offered
10.9.5 Redax Recent Development
10.10 Sarstedt
10.10.1 Sarstedt Company Information
10.10.2 Sarstedt Introduction and Business Overview
10.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sarstedt Cardiopulmonary Autotransfusion Systems Products Offered
10.10.5 Sarstedt Recent Development
10.11 Stryker
10.11.1 Stryker Company Information
10.11.2 Stryker Introduction and Business Overview
10.11.3 Stryker Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Stryker Cardiopulmonary Autotransfusion Systems Products Offered
10.11.5 Stryker Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cardiopulmonary Autotransfusion Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cardiopulmonary Autotransfusion Systems Industrial Chain Analysis
11.4 Cardiopulmonary Autotransfusion Systems Market Dynamics
11.4.1 Cardiopulmonary Autotransfusion Systems Industry Trends
11.4.2 Cardiopulmonary Autotransfusion Systems Market Drivers
11.4.3 Cardiopulmonary Autotransfusion Systems Market Challenges
11.4.4 Cardiopulmonary Autotransfusion Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cardiopulmonary Autotransfusion Systems Distributors
12.3 Cardiopulmonary Autotransfusion Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock